EICHORCondition: Hypoparathyroidism · Sponsor: European Georges Pompidou Hospital
Sponsor, CRO or site team? See where this study is running → — listed sites, countries and recruiting context. Everything below is written for patients and caregivers.
Very few data has been published on the epidemiology of hypoparathyroidism worldwide: none exists specifically for France. Hypoparathyroidism could led to complications. Here, the investigators plan to collect data about both epidemiology, medication and complication of hypoparathyroidism in France.
This description comes directly from the study's public registry record.
Jean-Philippe Bertocchio, MD, PhD · 800-555-5555 · jpbertocchio@gmail.com
Pascal Houillier, MD, PhD · 800-555-5555 · pascal.houillier@aphp.fr
Always discuss trial participation with your own doctor first.
| Felix Guyon Hospital | Saint-Denis, La Réunion, France | Recruiting |
| Hôpital Privé de Provence | Aix-en-Provence, France | Recruiting |
| Amiens University Hospital | Amiens, France | Recruiting |
| Clinic Auch Area | Auch, France | Recruiting |
| Henri Mondor Hospital | Aurillac, France | Recruiting |
| Jean Minjoz Hospital | Besançon, France | Recruiting |
| Blanquefort | Blanquefort, France | Recruiting |
| Avicenne Hospital, AP-HP | Bobigny, France | Recruiting |
| Jean Verdier Hospital, AP-HP | Bondy, France | Recruiting |
| University Hospital | Bordeaux, France | Recruiting |
| Bourgoin Jallieu Hospital | Bourgoin, France | Recruiting |
| La Cavale Blanche Hospital | Brest, France | Recruiting |
+ 45 more locations — full list on the registry record.
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice. By subscribing you agree to our Terms of Use and Privacy Policy.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT02838927